About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Chicago | 113 Studies

Clinical Trials Multiple SclerosisChicago

Multiple Sclerosis Clinical Trials in Chicago

Find 113 clinical trials for multiple sclerosis near Chicago, Illinois. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 113 trials

UnknownPhysiology of Interregional Connectivity in the Human BrainThe purpose of this study is to understand the physiology of connectivity between cortical regions in the human brain in healthy participants and in patients with white matter…NCT03723434·Chicago, Illinois TerminatedAn Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)This study will investigate the efficacy, safety and tolerability of a new formulation of glatiramer acetate administered at 20 mg/0.5 ml daily versus placebo in patients with…NCT01578785·Cullman, Alabama and 168 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedProspective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With OcrelizumabOpen-label, prospective, single-arm, multi-center study to assess disease activity and biomarker of neuronal damage in minority patients (self-identified Black or African American…NCT04377555·Phoenix, Arizona and 27 others

TerminatedEffect of MD1003 in Progressive Multiple Sclerosis (SPI2)The purpose of this study is to demonstrate the superiority of MD1003 over placebo in the disability of patients suffering from progressive multiple sclerosis and especially those…NCT02936037·Phoenix, Arizona and 91 others

TerminatedNivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseThe purpose of this study is to explore the safety, tolerability and activity of Nivolumab, a PD-1 inhibitor, in cohorts of patients with autoimmune disease.NCT03656627·Chicago, Illinois and 8 others

RecruitingIntermittent Hypoxia in Persons With Multiple SclerosisThis study aims to understand the mechanisms of a novel intervention involving breathing short durations of low levels of oxygen for persons with multiple sclerosis (MS).NCT06276634·Chicago, Illinois

TerminatedFeasibility of the Multiple Sclerosis Performance Test in Participants With Multiple SclerosisThe primary objective is to evaluate the feasibility of the Multiple Sclerosis Performance Test (MSPT) in a clinical care setting when used by participants with Multiple Sclerosis…NCT03926637·Berkeley, California and 32 others

CompletedA Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple SclerosisStudy Title: A Serologic Study to Correlate b-IFN NAb titers to b-IFN Induced Biomarker Response in Patients with Multiple Sclerosis Objectives: Subjects currently on any of the…NCT00288990·Birmingham, Alabama and 27 others

RecruitingRE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesThe purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in…NCT07002034·Birmingham, Alabama and 31 others

SuspendedStudy of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory IssuesThis study is for people who have multiple sclerosis, acute leukemia (in remission), or long-COVID and a Body Mass Index over 27 and may struggle with cognitive issues such as…NCT06171152·Chicago, Illinois

Active not recruitingEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)NCT05147220·Phoenix, Arizona and 199 others

Active not recruitingRemote Therapeutic Monitoring Exercise TrackingThe purpose of this study is to examine physical activity and exercise behaviors in people with Parkinson's Disease and Multiple Sclerosis over the course of 1-year using a…NCT06306768·Chicago, Illinois

Active not recruitingEvaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and PainThe purpose of this study is to to explore the safety and efficacy of the EXOPULSE Mollii suit, a full-body electrostimulation suit, for individuals with neurological or…NCT07132775·Chicago, Illinois

CompletedTysabri Effects on Cognition and Neurodegeneration in Multiple SclerosisThe long-term objective is to further establish the role of Tysabri in preventing neurological degeneration in multiple sclerosis (MS) and to establish powerful and efficient new…NCT01071512·Chicago, Illinois

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 TrialThe purpose of the study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months in patients who previously…NCT00649792·Phoenix, Arizona and 41 others

CompletedA Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During PregnancyThis study will evaluate the potential placental transfer of ocrelizumab in pregnant women with clinically isolated syndrome (CIS) or multiple sclerosis (MS) \[in line with the…NCT04998812·San Francisco, California and 10 others

CompletedDimethyl Fumarate (DMF) Observational StudyThe primary objective of the study is to determine the incidence, type, and pattern of serious adverse events (SAEs), including but not limited to infections (including…NCT02047097·Birmingham, Alabama and 467 others

CompletedA Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple SclerosisThis randomized, double-blind, double-dummy, parallel-group study will evaluate the efficacy and safety of ocrelizumab in comparison with interferon beta-1a (Rebif) in…NCT01247324·Phoenix, Arizona and 141 others

UnknownFall Prevention Program for Non-ambulatory Wheeled Mobility Device Users Living With MSA research study to examine the effectiveness of a fall management program to prevent falls and develop fall recovery strategies for wheeled mobility device users living with…NCT03705364·Atlanta, Georgia and 2 others

CompletedEffects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple SclerosisNearly 1 million individuals in the United States have multiple sclerosis, which causes fatigue and problems with walking.NCT06264336·Chicago, Illinois

PreviousPage 4 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia